Resistance Training as an Aid to Smoking Cessation Treatment

March 19, 2020 updated by: Teachers College, Columbia University
The purpose of this study is to determine whether resistance training can aid smoking cessation.

Study Overview

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10027
        • Teachers College, Columbia University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Age 18 or older, smoke five or more cigarettes a day for at least the past 12 months

Exclusion Criteria:

Participating in any type of exercise for >60 minutes/week over the past 3 months, current smokeless tobacco use, participation in an ongoing effort to quit smoking, current or planned pregnancy, any serious medical condition that would make exercise unsafe

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Resistance training
Participants will attend two, 45-60-minute progressive, moderate intensity resistance training sessions per week for 12 weeks. The program will maintain a format of a 5-minute warm-up, 35-50 minutes of resistance training and a 5-minute cool-down with flexibility and abdominal exercises.
ACTIVE_COMPARATOR: Health and Wellness
Participants in this group will be required to attend the exact same number of sessions as those in the Resistance Training group. Each session will last approximately 45-60 minutes. Sessions will include a practical component/demonstration, an informational video, and a handout on a pertinent healthy lifestyle topic for adults.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Smoking cessation
Time Frame: Change from baseline to 3 months
Salivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking).
Change from baseline to 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cortisol
Time Frame: 3, 6, 12 months
3, 6, 12 months
Mood
Time Frame: 3, 6, 12 months
3, 6, 12 months
Cigarette cravings
Time Frame: 3, 6, 12 months
3, 6, 12 months
Abstinence self-efficacy
Time Frame: 3, 6, 12 months
3, 6, 12 months
Sleep
Time Frame: 3, 6, 12 months
3, 6, 12 months
Body composition
Time Frame: 3, 6, 12 months
3, 6, 12 months
Body weight
Time Frame: 3, 6, 12 months
3, 6, 12 months
Lung function
Time Frame: 3, 6, 12 months
3, 6, 12 months
Blood pressure
Time Frame: 3, 6, 12 months
3, 6, 12 months
Cholesterol profile
Time Frame: 3, 6, 12 months
3, 6, 12 months
Glycosylated hemoglobin
Time Frame: 3, 6, 12 months
3, 6, 12 months
Muscular strength
Time Frame: 3, 6, 12 months
3, 6, 12 months
Aerobic fitness
Time Frame: 3, 6, 12 months
Six-minute walk test
3, 6, 12 months
Smoking cessation
Time Frame: Change from baseline to 6 months
Salivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking).
Change from baseline to 6 months
Smoking cessation
Time Frame: Change from baseline to 12 months
Salivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking).
Change from baseline to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (ACTUAL)

March 31, 2019

Study Completion (ACTUAL)

March 31, 2019

Study Registration Dates

First Submitted

September 10, 2013

First Submitted That Met QC Criteria

September 23, 2013

First Posted (ESTIMATE)

September 26, 2013

Study Record Updates

Last Update Posted (ACTUAL)

March 20, 2020

Last Update Submitted That Met QC Criteria

March 19, 2020

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 1R01HL117345-01A1 (NIH)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cigarette Smoking

Clinical Trials on Resistance training

Subscribe